ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft function"

  • 2016 American Transplant Congress

    Prognosis Value of the Presence and Persistence of C1q Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation.

    E. Bailly,1 B. Proust,2 M. Giral,3 V. Vuiblet,4 V. Chatelet,5 E. Morelon,6 P. Malvezzi,7 S. Caillard,8 B. Barrou,9 L. Couzi,10 J. Sayegh,11 C. Mousson,12 D. Anglicheau,13 P. Grimbert,14 M. Hazzan,15 G. Mourad,16 R. Purgus,17 P. Westeel,18 Y. Lebranchu,1,19 M. Büchler.1,19

    1CHU, Tours, France; 2EFS Centre Atlantique, Tours, France; 3ITUN, Nantes, France; 4CHU, Reims, France; 5CHU, Caen, France; 6CHU, Lyon, France; 7CHU, Grenoble, France; 8CHU, Strasbourg, France; 9Hôpital la Pitié Salpêtrière, Paris, France; 10CHU, Bordeaux, France; 11CHU, Angers, France; 12CHU, Dijon, France; 13Hôpital Necker, Paris, France; 14Hôpital Henri Mondor, Paris, France; 15CHU, Lille, France; 16CHU, Montpellier, France; 17CHU, Marseille, France; 18CHU, Amiens, France; 19Université F. Rabelais, Tours, France.

    Purpose : Longitudinal study of C1q complement fraction binding capacity of donor specific anti-HLA antibodies (DSAs) as a pronostic marker in acute antibody-mediated rejection.Methods :…
  • 2016 American Transplant Congress

    Imminent Death Donation: Potential Effects on Organ Donation Numbers and Clinical Outcomes.

    V. Potluri,1 S. Nazarian,2 M. Levine,2 P. Reese.3

    1Internal Medicine, Lankenau Hospital, Wynnewood; 2Transplant Surgery, University of Pennsylvania, Philadelphia; 3Renal Division, University of Pennsylvania, Philadelphia.

    Attempts at donation after cardiac death (DCD) lead to organ transplantation only among 70% of eligible DCDs. Imminent death donation (IDD) is ante-mortem donation of…
  • 2016 American Transplant Congress

    Acute Inflammation, Chronic Damage and Renal Dysfunction in Renal Transplant Recipients with Delayed Graft Function (DGF).

    A. Cherukuri, R. Mehta, P. Sood, P. Randhawa, A. Tevar, S. Hariharan.

    UPMC, Pittsburgh.

    Analysis of DGF and clinical outcomes in relation to progressive histological changes is not well reported. In this prospective longitudinal study, patients with DGF were…
  • 2016 American Transplant Congress

    Human B Cell Cytokines Predict Renal Allograft Rejection and Early Transplant Outcomes.

    A. Cherukuri, R. Mehta, S. Ogunde, S. Hariharan, D. Rothstein.

    UPMC, Pittsburgh.

    In renal transplantation, non-invasive biomarkers that are predictive and allow for early intervention are limited. Here we report findings from a prospective longitudinal study of…
  • 2016 American Transplant Congress

    Cinacalcet Versus Pre-Transplant Parathyroidectomy in Renal Transplant Recipients: Single Centre Experience.

    G. Lucisano,1 R. Charif,1 K. Koutroutsos,1 D. Taube,1 F. Palazzo,2 M. Loucaidou.1

    1Renal and Transplant Medicine, Imperial College Healthcare NHS Trust, London, United Kingdom; 2Centre for Endocrinology, Imperial College Healthcare NHS Trust, London, United Kingdom.

    Introduction:Hyperparathyroidism(HPT) often persists after renal transplantation(Tx). Cinacalcet(Cx) and parathyroidectomy(PTx) are possible treatments. It was reported that PTx may be followed by a reduction in Tx…
  • 2016 American Transplant Congress

    Tocilizumab as Treatment for Persistent Chronic Active Antibody Mediated Rejection.

    H. Fernandez, S. Patel, M. Chiles, L. Ratner, R. Crew.

    Columbia University Medical Center, NYC.

    Intro: CAAMR is an increasingly recognized cause of renal allograft failure with limited treatment options. Many patients with CAAMR have engagement of both T and…
  • 2016 American Transplant Congress

    Robotic Kidney Transplantation in Obese Recipients Can Lead to Superior Outcomes in Terms of Wound Infection and Graft Survival – 48 Months of Follow-up.

    I. Tvetanov, S. Garcia Aroz, M. Spaggiari, J. Hoonbae, J. Oberholzer, E. Benedetti.

    Surgery, University of Illinois, Chicago, IL.

    Introduction: Traditionally kidney transplantation (KT) in obese recipients has been associated with high rates of surgical site infections (SSI). We hypothesize that robotic kidney transplantation…
  • 2016 American Transplant Congress

    Associations Between Deceased-Donor Urine MCP-1 and Kidney Transplant Outcomes.

    S. Mansour,1 J. Puthumana,1 P. Reese,2 I. Hall,1 M. Doshi,3 F. Weng,4 B. Schröppel,5 H. Thiessen-Philbrook,1,6 M. Bimali,1 C. Parikh.1

    1Nephrology, Yale University School of Medicine, New Haven, CT; 2Renal-Electrolyte and Hypertension, University of Pennsylvania, Philadelphia, PA; 3Wayne State University, Detroit, MI; 4Saint Barnabas Medical Center, Livingston, NJ; 5Nephrology, University Hospital, Ulm, Germany; 6Nephrology, Western University, London, ON, Canada.

    Current assessments of deceased donor kidneys lack precision in predicting recipient graft function. Mouse models have demonstrated that monocyte chemoattractant protein-1 (MCP-1) has a pivotal…
  • 2015 American Transplant Congress

    Clinical and Pathologic Predictors of Response to Belatacept Conversion

    S. Patel, H. Morris, D. Cohen, S. Mohan, L. Ratner, R. Crew.

    Columbia Universtiy, New York.

    INTRO: Calcineurin inhibitors have improved kidney transplant and recipient survival, their use has significant nephrotoxicity. Belatacept is a recently approved immunosuppressant that is not nephrotoxic…
  • 2015 American Transplant Congress

    Transversal Observational Study On Recurrent and Late Urinary Tract Infections (UTIs) in Renal Transplantation (tx)

    G. Castellano,1 M. Fiorentino,1 M. Martino,1 M. Rossini,1 A. Schena,1 C. Manno,1 G. Grandaliano,2 P. Ditonno,3 M. Battaglia,3 L. Gesualdo.1

    1DETO, Nephrology, Dialysis and Transplantation Unit, University of Bari, Bari, Italy; 2Department of Medical and Surgical Sciences, Nephrology, Dialysis and Transplantation Unit, University of Foggia, Foggia, Italy; 3DETO, Andrology, Urology and Renal Transplantation Unit, University of Bari, Bari, Italy.

    UTIs are common complications after kidney tx. The aim of this study was to define the potential predisposing factors and the possible impact on graf…
  • « Previous Page
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • …
  • 64
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences